Dai Xiao Chang - Net Worth and Insider Trading
Dai Xiao Chang Net Worth
The estimated net worth of Dai Xiao Chang is at least $765,000 dollars as of 2025-05-04. Dai Xiao Chang is the senior management of KPC Pharmaceuticals Inc and owns about 50,000 shares of KPC Pharmaceuticals Inc (SHSE:600422) stock worth over $765,000. Details can be seen in Dai Xiao Chang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dai Xiao Chang has not made any transactions after 2016-09-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Dai Xiao Chang
Dai Xiao Chang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dai Xiao Chang owns 1 companies in total, including KPC Pharmaceuticals Inc (SHSE:600422) .
Click here to see the complete history of Dai Xiao Chang’s form 4 insider trades.
Insider Ownership Summary of Dai Xiao Chang
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:600422 | KPC Pharmaceuticals Inc | 2016-09-12 | senior management |
Dai Xiao Chang Latest Holdings Summary
Dai Xiao Chang currently owns a total of 1 stock. Dai Xiao Chang owns 50,000 shares of KPC Pharmaceuticals Inc (SHSE:600422) as of September 12, 2016, with a value of $765,000.
Latest Holdings of Dai Xiao Chang
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:600422 | KPC Pharmaceuticals Inc | 2016-09-12 | 50,000 | 15.30 | 765,000 |
Holding Weightings of Dai Xiao Chang
Dai Xiao Chang Form 4 Trading Tracker
According to the SEC Form 4 filings, Dai Xiao Chang has made a total of 0 transactions in KPC Pharmaceuticals Inc (SHSE:600422) over the past 5 years. The most-recent trade in KPC Pharmaceuticals Inc is the sale of 50,000 shares on September 12, 2016, which brought Dai Xiao Chang around $0.
Insider Trading History of Dai Xiao Chang
- 1
Dai Xiao Chang Trading Performance
GuruFocus tracks the stock performance after each of Dai Xiao Chang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dai Xiao Chang is -6.39%. GuruFocus also compares Dai Xiao Chang's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dai Xiao Chang within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dai Xiao Chang's insider trading performs compared to the benchmark.
Performance of Dai Xiao Chang
Dai Xiao Chang Ownership Network
Ownership Network List of Dai Xiao Chang
Ownership Network Relation of Dai Xiao Chang

Dai Xiao Chang Owned Company Details
What does KPC Pharmaceuticals Inc do?
Who are the key executives at KPC Pharmaceuticals Inc?
Dai Xiao Chang is the senior management of KPC Pharmaceuticals Inc. Other key executives at KPC Pharmaceuticals Inc include senior management Qu Xiao Ru , senior management Xie Bo , and senior management Meng Li .
KPC Pharmaceuticals Inc (SHSE:600422) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of KPC Pharmaceuticals Inc (SHSE:600422) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of KPC Pharmaceuticals Inc (SHSE:600422) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
KPC Pharmaceuticals Inc (SHSE:600422)'s detailed insider trading history can be found in Insider Trading Tracker table.
KPC Pharmaceuticals Inc Insider Transactions
Dai Xiao Chang Mailing Address
Above is the net worth, insider trading, and ownership report for Dai Xiao Chang. Currently GuruFocus does not have mailing address information for Dai Xiao Chang.